---
title: CDMO Daily News — June 11, 2026
slug: daily-news-2026-06-11-cdmo
site: cdmo
post_kind: news
byline: BioBM
last_updated: 2026-06-11T05:46:54.699Z
---

### Scinai Completes Recipharm Israel Acquisition, Expands CDMO Platform to Two Sites
- Scinai acquired Recipharm Israel's Yavne facility, adding a second manufacturing site and $3.6 million in equipment to complement its Jerusalem biologics operation.
- The combined CDMO platform now offers biologics, sterile injectables, and small-molecule API development and manufacturing across two Israeli locations.
- Q1 2026 CDMO revenues included ~$200K from the newly acquired Yavne facility; Scinai entered a strategic commercial collaboration with global CDMO leader [Recipharm AB](/companies/recipharm-ab).

**Operational Impact**

Scinai's acquisition of Recipharm Israel's Yavne facility expands its CDMO service portfolio from biologics-only to include sterile injectables and small-molecule APIs, broadening the addressable customer base and manufacturing footprint across two Israeli sites.

*Source: [PR Newswire pharma category RSS](https://www.prnewswire.com/news-releases/scinai-reports-first-quarter-2026-financial-results-and-provides-corporate-update-highlighting-expansion-of-cdmo-platform-and-advancement-of-strategic-growth-initiatives-302796684.html)*

## References

1. [PR Newswire pharma category RSS — Scinai Completes Recipharm Israel Acquisition, Expands CDMO Platform to Two Sites](https://www.prnewswire.com/news-releases/scinai-reports-first-quarter-2026-financial-results-and-provides-corporate-update-highlighting-expansion-of-cdmo-platform-and-advancement-of-strategic-growth-initiatives-302796684.html)

Source: https://cdmo.directory/posts/daily-news-2026-06-11-cdmo